Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis Patients
Condition: Secondary Progressive Multiple Sclerosis Interventions: Drug: Rituximab; Drug: Glatiramer Acetate Sponsor: Isfahan University of Medical Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials